01
Embedded Medical Monitor
Our co-founder and CMO, Dr. Dipali Patel, is an experienced medical monitor working inside the network. Safety and eligibility questions get physician-level answers in hours, not escalation chains.
For Sponsors And CROs
Sites That Come With The Patients Already In Them
Traditional sites recruit strangers with ad budgets. Stryde sites are built inside specialty practices, so the eligible patients are already in the EMR, already seeing the PI, already showing up. That is why startup and enrollment run faster here, and why we publish the numbers.
Request FeasibilityShort answer: shortlist Stryde when your protocol needs outpatient enrollment in dermatology, rheumatology, or community specialty medicine, when diversity targets matter, or when a study needs rescue. Our sites sit inside specialty practices, so eligible patients are already in the EMR and already trust the investigator. That is the mechanism behind every number below, and where we are not the right fit, we say so.
What Do You Get That A Site List Can’t Show?
02
Diversity By Design, Not By Campaign
Our practices serve the communities they sit in, across DFW, Houston, Louisiana, and NJ/NY, so representative enrollment is a structural property of the model. Network aggregates are published on the performance board.
03
Cell And Gene Ready
NIH IBC-RMS approval in place for advanced therapy trials.
04
One Contract, Many Sites
A multi-geography investigator network under a single operational and quality system, with central regulatory, quality, and finance teams.
Benchmarks are on our performance board; see the full community-versus-academic comparison.
How Do We Build Enrollment Numbers?
Bottom-up, never from prevalence. Active patient counts from practice EMRs, protocol filters applied in sequence, realistic screen-failure rates by study type, and coordinator capacity applied as a hard ceiling. The result is a number we would actually commit to. The full method, with a worked example, is on how we build an enrollment number.
When Should A Sponsor Choose A Community Site Over An Academic Site?
Stryde Embedded Sites
Academic Medical Centers
01
Best For
Outpatient enrollment at the treatment-decision moment; diversity targets; rescue timelines
Complex inpatient protocols; first-in-human units; KOL-anchored science
02
Patient Source
The practice's own panel, already in the EMR
Referrals, often after key treatment decisions were made elsewhere
03
Startup
6.5-week network median; as fast as two weeks when sponsor needs and documents allow
Published medians of 69 days (university) to 167 days (cancer centers)
04
Retention Driver
Existing physician relationship; visits at the patient's usual clinic
Study-built relationship
Benchmark sources are on the performance board; read the full community sites vs academic centers comparison.
Where Are We A Strong Fit, And Where Aren’t We?
Outpatient Phase 2–4 in dermatology, rheumatology, and our active specialties
Biologic and injectable protocols (infusion capability, cold chain in place)
Rare disease work where community specialists hold the panel
Protocols with FDA diversity action plan targets
Studies needing rescue sites with pre-tagged eligible patients
Indications requiring infrastructure our practices do not offer; an academic site may serve you better, and we will say so in the feasibility response
Therapeutic Coverage
Dermatology
Core specialty → capabilities
Rheumatology
Core specialty → capabilities
Cardiology
Active
Pulmonology
Active
Neurology
Active
Psychiatry
Active
Gastroenterology
Active
Allergy & Immunology
Active
General & Internal Medicine
Active
Pediatrics
ActiveSend Us Your Protocol Synopsis. Preliminary Feasibility In 48 Business Hours, Or We’ll Tell You Why Not Within 4.
Frequently Asked Questions (FAQs)
Stryde Research is a physician-owned Site Management Organization (SMO+) that runs clinical trials inside specialty physician practices. The network spans 20+ embedded research sites across Texas, Louisiana, New Jersey, and New York, with access to 1.5M+ patients across 100+ specialty clinics.
A dedicated facility recruits unfamiliar patients through advertising. An embedded site places research staff inside an existing specialty practice, so eligible patients are already in the EMR and already trust the investigator. The result is faster startup, faster enrollment, and better retention.
Preliminary feasibility in 48 business hours, or an honest answer within 4 hours explaining why a protocol needs longer. Preliminary includes PI interest, an estimated eligible population from network data, a realistic enrollment range, and capability fit.
Yes. The network holds NIH IBC-RMS approval for advanced therapy trials, alongside experience across dermatology, rheumatology, neurology, pulmonology, and additional specialties.
By geography rather than campaigns. Our sites sit inside community practices serving South Asian, Black, Hispanic, and immigrant communities across our markets, so representative enrollment is a structural feature of the model, not an advertising outcome.
Want outcomes, not claims? See network results. Before the pitch, see our live performance metrics, enrollment results from real studies, or the way we build enrollment numbers.